Discussion on: Effectiveness and Safety of 35 kDa Hyaluronan for Symptom Relief in Advanced Lung Cancer: A Pilot Study Focusing on Pain and Cough

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title 
Effectiveness and Safety of 35 kDa Hyaluronan for Symptom Relief in Advanced Lung Cancer: A Pilot Study Focusing on Pain and Cough
Authored by
Sunjidmaa
Department of Pulmonary and Critical Care Medicine, Tuya Amglan Hospital, Ulaanbaatar, Mongolia.

Dylan Treger
Miller School of Medicine, University of Miami, Florida, United States.

Xiaoxiao Jia
Hynaut Laboratories, Hynaut Group, Qingdao, China.

Jessica Hui
Hynaut Laboratories, Hynaut Group, Qingdao, China.

Taivanbat Ganbaatar
Pharmaceutical Manufacture Department, Nakhia Impex Pharmaceutical Co., Ltd., Ulaanbaatar, Mongolia.

Bat-erdene Ganbaatar
Pharmaceutical Manufacture Department, Nakhia Impex Pharmaceutical Co., Ltd., Ulaanbaatar, Mongolia.

Zhaohui Ma
Hynaut Laboratories, Hynaut Group, Qingdao, China.

Mizhou Hui
Hynaut Laboratories, Hynaut Group, Qingdao, China.

DOI or Article Link

https://doi.org/10.9734/aorj/2025/v8i1101

Leave a Comment